NCT02725528 2023-07-18
EXTEND
McMaster University
Phase 3 Completed
Clinical Trials
6 trialsNCT00528606 2017-12-02
CORD-I
Endo Pharmaceuticals
Phase 3 Completed
NCT01407068 2017-10-05
Administration of Two Injections for Multiple Dupuytren's Contractures
Endo Pharmaceuticals
Phase 3 Completed
NCT01588353 2017-03-21
CORD-J
Asahi Kasei Pharma Corporation
Phase 3 Completed
NCT01229436 2014-03-17
POINT X
Pfizer
Phase 3 Completed
NCT00260429 2010-12-09
Collagenase in the Treatment of Dupuytrens Disease
Stony Brook University
Phase 3 Completed